Publications 2024

Bachmann CJ, Scholle O, Bliddal M, dosReis S, Odsbu I, Skurtveit S, Wesselhoeft R, Vivirito A, Zhang C, Scott S (2024)
Recognition and management of children and adolescents with conduct disorder: a real-world data study from four western countries
Child Adolesc Psychiatry Ment Health, 18 (1), 18
DOI 10.1186/s13034-024-00710-6, PubMed 38281951

Baumann-Larsen M, Storheim K, Stangeland H, Zwart JA, Wentzel-Larsen T, Skurtveit S, Dyb G, Stensland SØ (2024)
Childhood trauma and the use of opioids and other prescription analgesics in adolescence and young adulthood: The HUNT Study
Pain, 165 (6), 1317-1326
DOI 10.1097/j.pain.0000000000003131, PubMed 38126936

Høibø T, Skurtveit S, Lid TG (2024)
Is general practitioner involvement in the initiation of opioids for chronic non-cancer pain associated with opioid dose and concurrent drug use?
Scand J Prim Health Care, 1-4 (in press)
DOI 10.1080/02813432.2024.2404053, PubMed 39300757

Kostovski E, Hamina A, Hjellvik V, Clausen T, Skurtveit S (2024)
Increased cancer incidence and mortality among people with opioid use-related disorders: A nation-wide cohort study
Addiction, 119 (9), 1575-1584
DOI 10.1111/add.16524, PubMed 38775233

McDonald R, Eide D, Skurtveit S, Clausen T (2024)
Pills and the damage done: the opioid epidemic as man-made crisis
Front Public Health, 11, 1241404
DOI 10.3389/fpubh.2023.1241404, PubMed 38283292

Nestvold HH, Skurtveit S, Hamina A, Hjellvik V, Odsbu I (2024)
The risk of long-term opioid use among immigrants: a national registry-linkage study
Scand J Public Health, 14034948241266744 (in press)
DOI 10.1177/14034948241266744, PubMed 39169861

Nøst TH, Skurtveit S, Odsbu I, Pedersen L, Borchgrevink PC, Handal M (2024)
Prevalence of substance use disorder diagnoses in patients with chronic pain receiving reimbursed opioids: An epidemiological study of four Norwegian health registries
Scand J Pain, 24 (1)
DOI 10.1515/sjpain-2024-0059, PubMed 39687976

Odsbu I, Hjellvik V, Handal M, Hamina A, Clausen T, Lid TG, Borchgrevink PC, Skurtveit S (2024)
[Mental disorders and symptoms with persistent opioid use for chronic non-cancer pain – a registry study]
Tidsskr Nor Laegeforen, 144 (2)
DOI 10.4045/tidsskr.23.0414, PubMed 38349107

Rasmussen L, Jensen PB, Reutfors J, Furu K, Skurtveit S, Selmer R, Damkier P, Bliddal M, Wesselhoeft R (2024)
Treatment patterns of antidepressants in children and adolescents in Scandinavia
Eur Child Adolesc Psychiatry (in press)
DOI 10.1007/s00787-024-02433-7, PubMed 38683400

Rolová G, Skurtveit S, Gabrhelík R, Mravčík V, Odsbu I (2024)
Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway
Addict Sci Clin Pract, 19 (1), 37
DOI 10.1186/s13722-024-00467-5, PubMed 38741162

Sharikabad MN, Skurtveit S, Sommerschild HT, Olsen K, Hartz I, Wesselhoeft R, Hjellvik V, Hauge LJ, Handal M (2024)
Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study
J Clin Med, 13 (4)
DOI 10.3390/jcm13041075, PubMed 38398388

Vambheim SM, Hjellvik V, Odsbu I, Skurtveit S, Ekholdt C, Granan LP, Stubhaug A, Samuelsen PJ (2024)
Postoperative opioid use in Norway-a population-based observational study on patterns of long-term use
BMC Pharmacol Toxicol, 25 (1), 81
DOI 10.1186/s40360-024-00805-y, PubMed 39456108

Publications 2023

Eide D, McDonald R, Hamina A, Clausen T, Odsbu I, Skurtveit S (2023)
Prescription high-risk polysubstance use among opioid maintenance treatment patients
Int J Drug Policy, 104196 (in press)
DOI 10.1016/j.drugpo.2023.104196, PubMed 37741700

Eide D, Skurtveit S, Clausen T, Hesse M, Mravčík V, Nechanská B, Rolova G, Thylstrup B, Tjagvad C, Seid AK, Odsbu I, Gabrhelík R (2023)
Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study
Eur Addict Res, 29 (4), 272-284
DOI 10.1159/000530822, PubMed 37385232

Eriksen AMA, Melhus M, Schei B, Skurtveit S, Broderstad AR (2023)
Opioid prescriptions among Sami and non-Sami with chronic pain: The SAMINOR 2 Questionnaire Survey and the Norwegian Prescription Database
Int J Circumpolar Health, 82 (1), 2241202
DOI 10.1080/22423982.2023.2241202, PubMed 37506380

Gabrhelík R, Hesse M, Nechanská B, Handal M, Mravčík V, Tjagvad C, Thylstrup B, Seid AK, Bukten A, Clausen T, Skurtveit S (2023)
Large variations in all-cause and overdose mortality among >13,000 patients in and out of opioid maintenance treatment in different settings: a comparative registry linkage study
Front Public Health, 11, 1179763
DOI 10.3389/fpubh.2023.1179763, PubMed 37809010

Gjerde LC, Skurtveit S, Handal M, Nesvåg R, Clausen T, Lid TG, Hamina A, Borchgrevink PC, Odsbu I (2023)
Mental disorder prevalence in chronic pain patients using opioid versus non-opioid analgesics: A registry-linkage study
Eur J Pain, 27 (7), 884-895
DOI 10.1002/ejp.2121, PubMed 37133299

Hamina A, Odsbu I, Hjellvik V, Lid TG, Clausen T, Skurtveit S (2023)
Fatal drug overdoses in individuals treated pharmacologically for chronic pain: a nationwide register-based study
Br J Anaesth, 132 (1), 86-95
DOI 10.1016/j.bja.2023.10.016, PubMed 37953201

Holmberg ST, Skurtveit S, Gulati S, Salvesen ØO, Nygaard ØP, Solberg TK, Fredheim OMS (2023)
Persistent Use of Prescription Opioids Before and After Lumbar Spine Surgery: Observational Study With Prospectively Collected Data From Two Norwegian National Registries
Spine (Phila Pa 1976), 48 (14), 969-977
DOI 10.1097/BRS.0000000000004710, PubMed 37163646

Odsbu I, Handal M, Hjellvik V, Hernandez-Diaz S, Kieler H, Nørgaard M, Skurtveit S, Esen BÖ, Mahic M (2023)
Prenatal opioid exposure and risk of asthma in childhood: a population-based study from Denmark, Norway, and Sweden
Front Pharmacol, 14, 1056192
DOI 10.3389/fphar.2023.1056192, PubMed 37214456

Rolová G, Eide D, Gabrhelík R, Odsbu I, Clausen T, Skurtveit S (2023)
Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway
Subst Abuse Treat Prev Policy, 18 (1), 47
DOI 10.1186/s13011-023-00557-8, PubMed 37507709

Publications 2022

Bukten A, Lokdam NT, Skjærvø I, Ugelvik T, Skurtveit S, Gabrhelík R, Skardhamar T, Lund IO, Havnes IA, Rognli EB, Chang Z, Fazel S, Friestad C, Hesse M, Lothe J, Ploeg G, Dirkzwager AJE, Clausen T, Tjagvad C, Stavseth MR (2022)
PriSUD-Nordic-Diagnosing and Treating Substance Use Disorders in the Prison Population: Protocol for a Mixed Methods Study
JMIR Res Protoc, 11 (3), e35182
DOI 10.2196/35182, PubMed 35320114

Gabrhelík R, Skurtveit S, Nechanská B, Mravčík V, Handal M (2022)
Morbidity through 3 Years of Age in Children of Women Using Methamphetamine during Pregnancy: A National Registry Study
Eur Addict Res, 29 (1), 19-29
DOI 10.1159/000527238, PubMed 36423599

Hamina A, Hjellvik V, Handal M, Odsbu I, Clausen T, Skurtveit S (2022)
Describing long-term opioid use utilizing Nordic prescription registers-A Norwegian example
Basic Clin Pharmacol Toxicol, 130 (4), 481-491
DOI 10.1111/bcpt.13706, PubMed 35037407

Hamina A, Muller AE, Clausen T, Skurtveit S, Hesse M, Tjagvad C, Thylstrup B, Odsbu I, Zoega H, Jónsdóttir HL, Taipale H (2022)
Prescription opioids among older adults: ten years of data across five countries
BMC Geriatr, 22 (1), 429
DOI 10.1186/s12877-022-03125-0, PubMed 35578167

Hamina A, Odsbu I, Borchgrevink PC, Chen LC, Clausen T, Espnes KA, Gjesdal K, Handal M, Hartikainen S, Hjellvik V, Holter MTS, Høibø T, Kurita GP, Langaas HC, Lid TG, Nøst TH, Sjøgren P, Skurtveit S, POINT study group (2022)
Cohort Description: Preventing an Opioid Epidemic in Norway - Focusing on Treatment of Chronic Pain (POINT) - A National Registry-Based Study
Clin Epidemiol, 14, 1477-1486
DOI 10.2147/CLEP.S382136, PubMed 36523790

Heger K, Skipsfjord J, Kiselev Y, Burns ML, Aaberg KM, Johannessen SI, Skurtveit S, Johannessen Landmark C (2022)
Changes in the use of antiseizure medications in children and adolescents in Norway, 2009-2018
Epilepsy Res, 181, 106872
DOI 10.1016/j.eplepsyres.2022.106872, PubMed 35180640

Lund IO, Andersen N, Handal M, Ask H, Skurtveit S, Ystrom E, Burdzovic Andreas J (2022)
Parental drinking, mental health and education, and extent of offspring's healthcare utilisation for anxiety/depression: A HUNT survey and registry study
Scand J Public Health, 51 (6), 902-910
DOI 10.1177/14034948221076212, PubMed 35331062

Odsbu I, Handal M, Borchgrevink PC, Clausen T, Skurtveit S (2022)
[Changes in opioid use in Norway must be taken with the utmost seriousness]
Tidsskr Nor Laegeforen, 142 (3)
DOI 10.4045/tidsskr.21.0909, PubMed 35170914

Odsbu I, Handal M, Hjellvik V, Borchgrevink PC, Clausen T, Nesvåg R, Skurtveit S (2022)
[Long-term use of opioids and concomitant use of other habit-forming drugs]
Tidsskr Nor Laegeforen, 142 (3)
DOI 10.4045/tidsskr.21.0659, PubMed 35170913

Skurtveit S, Odsbu I, Gjersing L, Handal M, Lid TG, Clausen T, Hamina A (2022)
Individuals Dying of Overdoses Related to Pharmaceutical Opioids Differ from Individuals Dying of Overdoses Related to Other Substances: A Population-Based Register Study
Eur Addict Res, 28 (6), 419-424
DOI 10.1159/000526145, PubMed 36174536

Sundbakk LM, Gran JM, Wood ME, Handal M, Skurtveit S, Nordeng H (2022)
Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood
JAMA Netw Open, 5 (12), e2246889
DOI 10.1001/jamanetworkopen.2022.46889, PubMed 36520439

Tiger M, Wesselhoeft R, Karlsson P, Handal M, Bliddal M, Cesta CE, Skurtveit S, Reutfors J (2022)
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia
J Affect Disord, 323, 292-298
DOI 10.1016/j.jad.2022.11.068, PubMed 36442654

Publications 2021

Bramness JG, Hjellvik V, Stubhaug A, Skurtveit S (2021)
Possible opioid-saving effect of cannabis-based medicine using individual-based data from the Norwegian Prescription Database
Basic Clin Pharmacol Toxicol, 130 (1), 84-92
DOI 10.1111/bcpt.13660, PubMed 34559439

Burdzovic Andreas J, Ask Torvik F, Ystrom E, Skurtveit S, Handal M, Martinez P, Laslett AM, Lund IO (2021)
Parental risk constellations and future alcohol use disorder (AUD) in offspring: A combined HUNT survey and health registries study
Psychol Addict Behav, 36 (4), 375-386
DOI 10.1037/adb0000681, PubMed 33734784

Fadnes LT, Aas CF, Vold JH, Leiva RA, Ohldieck C, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA, INTRO-HCV Study Group (2021)
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
PLoS Med, 18 (6), e1003653
DOI 10.1371/journal.pmed.1003653, PubMed 34061883

Fredheim OM, Skurtveit S, Sjøgren P, Aljabri B, Hjellvik V (2021)
Prescriptions of analgesics during chronic cancer disease trajectories: A complete national cohort study
Pharmacoepidemiol Drug Saf, 30 (11), 1504-1513
DOI 10.1002/pds.5329, PubMed 34251721

Gabrhelík R, Handal M, Mravčík V, Nechanská B, Tjagvad C, Thylstrup B, Hesse M, Minařík J, Jarkovský J, Bukten A, Clausen T, Skurtveit S (2021)
Opioid maintenance treatment in the Czech Republic, Norway and Denmark: a study protocol of a comparative registry linkage study
BMJ Open, 11 (5), e047028
DOI 10.1136/bmjopen-2020-047028, PubMed 33972343

Hamina A, Handal M, Fredheim O, Clausen T, Chen LC, Skurtveit S (2021)
Filled prescriptions for opioids among children and adolescents - A nationwide study from 2010 to 2018
Acta Anaesthesiol Scand, 65 (10), 1475-1483
DOI 10.1111/aas.13968, PubMed 34374072

Holdø I, Bramness JG, Handal M, Hansen BH, Hjellvik V, Skurtveit S (2021)
Association Between Prescribed Hypnotics in Infants and Toddlers and Later ADHD: A Large Cohort Study from Norway
Child Psychiatry Hum Dev, 52 (4), 533-543
DOI 10.1007/s10578-020-01039-9, PubMed 32772207

Holmberg ST, Fredheim OMS, Skurtveit S, Salvesen ØO, Nygaard ØP, Gulati AM, Solberg TK, Gulati S (2021)
Persistent Use of Prescription Opioids Following Lumbar Spine Surgery: Observational Study with Prospectively Collected Data From Two Norwegian Nationwide Registries
Spine (Phila Pa 1976), 47 (8), 607-614
DOI 10.1097/BRS.0000000000004275, PubMed 34798646

Skjærvø I, Clausen T, Skurtveit S, Bukten A (2021)
Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control
BMC Psychiatry, 21 (1), 563
DOI 10.1186/s12888-021-03518-2, PubMed 34772369

Torp HA, Skurtveit S, Skaga NO, Gustavsen I, Gran JM, Rosseland LA (2021)
Pre-injury dispensing of psychoactive prescription drugs in a ten years trauma population: a retrospective registry analysis
Scand J Trauma Resusc Emerg Med, 29 (1), 125
DOI 10.1186/s13049-021-00939-6, PubMed 34454541

Trønnes JN, Lupattelli A, Handal M, Skurtveit S, Ystrom E, Nordeng H (2021)
Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children
JAMA Netw Open, 4 (9), e2124324
DOI 10.1001/jamanetworkopen.2021.24324, PubMed 34524436

Wesselhoeft R, Rasmussen L, Jensen PB, Jennum PJ, Skurtveit S, Hartz I, Reutfors J, Damkier P, Bliddal M, Pottegård A (2021)
Use of hypnotic drugs among children, adolescents, and young adults in Scandinavia
Acta Psychiatr Scand, 144 (2), 100-112
DOI 10.1111/acps.13329, PubMed 34021908

Aas CF, Vold JH, Gjestad R, Skurtveit S, Lim AG, Gjerde KV, Løberg EM, Johansson KA, Fadnes LT, INTRO-HCV Study Group (2021)
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
Subst Abuse Treat Prev Policy, 16 (1), 20
DOI 10.1186/s13011-021-00354-1, PubMed 33639969

Publications 2020

Fredheim OM, Skurtveit S, Loge JH, Sjøgren P, Handal M, Hjellvik V (2020)
Prescription of analgesics to long-term survivors of cancer in early adulthood, adolescence, and childhood in Norway: a national cohort study
Pain, 161 (5), 1083-1091
DOI 10.1097/j.pain.0000000000001800, PubMed 31923046

Gabrhelík R, Mahic M, Lund IO, Bramness J, Selmer R, Skovlund E, Handal M, Skurtveit S (2020)
Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study
Eur Addict Res, 27 (2), 131-141
DOI 10.1159/000510821, PubMed 33040062

Gabrhelík R, Skurtveit S, Nechanská B, Handal M, Mahic M, Mravčík V (2020)
Prenatal Methamphetamine Exposure and Adverse Neonatal Outcomes: A Nationwide Cohort Study
Eur Addict Res, 27 (2), 97-106
DOI 10.1159/000509048, PubMed 32702698

Handal M, Skurtveit S, Mahic M, Øhman I, Wikner BN, Tjagvad C, Kieler H, Halmesmäki E, Lund IO (2020)
Opioid maintenance treatment of pregnant women in the Scandinavian countries
Nordisk Alkohol Nark, 37 (3), 298-312
DOI 10.1177/1455072520914114, PubMed 35308316

Huitfeldt A, Sundbakk LM, Skurtveit S, Handal M, Nordeng H (2020)
Associations of Maternal Use of Benzodiazepines or Benzodiazepine-like Hypnotics During Pregnancy With Immediate Pregnancy Outcomes in Norway
JAMA Netw Open, 3 (6), e205860
DOI 10.1001/jamanetworkopen.2020.5860, PubMed 32568398

Kiselev Y, Handal M, Hjellvik V, Reichborn-Kjennerud T, Stoltenberg C, Suren P, Havdahl A, Skurtveit S (2020)
Nationwide Study of Neuropsychiatric Comorbidity and Medicines Use in Children With Autism Spectrum Disorder in Norway
Front Psychiatry, 11, 596032
DOI 10.3389/fpsyt.2020.596032, PubMed 33363486

Mahic M, Hernandez-Diaz S, Wood M, Kieler H, Odsbu I, Nørgaard M, Öztürk B, Bateman BT, Hjellvik V, Skurtveit S, Handal M (2020)
In utero opioid exposure and risk of infections in childhood: A multinational Nordic cohort study
Pharmacoepidemiol Drug Saf, 29 (12), 1596-1604
DOI 10.1002/pds.5088, PubMed 32767610

Mravčík V, Nechanská B, Gabrhelík R, Handal M, Mahic M, Skurtveit S (2020)
Socioeconomic characteristics of women with substance use disorder during pregnancy and neonatal outcomes in their newborns: A national registry study from the Czech Republic
Drug Alcohol Depend, 209, 107933
DOI 10.1016/j.drugalcdep.2020.107933, PubMed 32109712

Skovlund E, Selmer R, Skurtveit S, Brandlistuen RE, Handal M (2020)
In utero exposure to analgesic opioids and language development in 5-year old children
Pharmacoepidemiol Drug Saf, 29 (6), 736-744
DOI 10.1002/pds.5009, PubMed 32383248

Skurtveit S, Hjellvik V, Sakshaug S, Borchgrevink PC, Larsen BM, Clausen T, Skovlund E, Heggen EE, Handal M (2020)
[Prescribing of opioids for chronic pain on reimbursable prescription]
Tidsskr Nor Laegeforen, 140 (15)
DOI 10.4045/tidsskr.20.0153, PubMed 33118769

Skurtveit S, Hjellvik V, Sakshaug S, Borchgrevink PC, Larsen BM, Clausen T, Skovlund E, Heggen EE, Handal M (2020)
Prescribing opioids on blue prescription for long term pain
Tidsskr. Nor. Laegeforen., 140 (15), 1552-1556

Vold JH, Gjestad R, Aas CF, Chalabianloo F, Skurtveit S, Løberg EM, Johansson KA, Fadnes LT, INTRO-HCV Study Group (2020)
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020
Subst Abuse Treat Prev Policy, 15 (1), 93
DOI 10.1186/s13011-020-00334-x, PubMed 33317568

Vold JH, Skurtveit S, Aas C, Chalabianloo F, Kloster PS, Johansson KA, Fadnes LT (2020)
Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
BMC Health Serv Res, 20 (1), 352
DOI 10.1186/s12913-020-05195-5, PubMed 32334602

Vold JH, Skurtveit S, Aas C, Johansson KA, Fadnes LT (2020)
Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013-2017): a prospective cohort study
BMC Health Serv Res, 20 (1), 668
DOI 10.1186/s12913-020-05504-y, PubMed 32690022

Vold JH, Aas C, Skurtveit S, Odsbu I, Chalabianloo F, Halmøy A, Johansson KA, Fadnes LT (2020)
Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
BMC Psychiatry, 20 (1), 119
DOI 10.1186/s12888-020-02526-y, PubMed 32164615

Vold JH, Aas C, Skurtveit S, Odsbu I, Chalabianloo F, Reutfors J, Halmøy A, Johansson KA, Fadnes LT (2020)
Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
BMJ Open, 10 (8), e036860
DOI 10.1136/bmjopen-2020-036860, PubMed 32771988

Welle-Strand GK, Skurtveit S, Abel KF, Chalabianloo F, Sarfi M (2020)
Living a normal life? Follow-up study of women who had been in opioid maintenance treatment during pregnancy
J Subst Abuse Treat, 113, 108004
DOI 10.1016/j.jsat.2020.108004, PubMed 32359675

Welle-Strand GK, Skurtveit S, Clausen T, Sundal C, Gjersing L (2020)
COVID-19 survey among people who use drugs in three cities in Norway
Drug Alcohol Depend, 217, 108302
DOI 10.1016/j.drugalcdep.2020.108302, PubMed 32961453

Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, Askildsen JE, Løberg EM, Fadnes LT, Johansson KA, INTRO-HCV Study Group (2020)
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
Subst Abuse Treat Prev Policy, 15 (1), 68
DOI 10.1186/s13011-020-00309-y, PubMed 32883319

Aas CF, Vold JH, Skurtveit S, Odsbu I, Chalabianloo F, Lim AG, Johansson KA, Fadnes LT (2020)
Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
Subst Abuse Treat Prev Policy, 15 (1), 44
DOI 10.1186/s13011-020-00286-2, PubMed 32605625

Aas CF, Vold JH, Skurtveit S, Odsbu I, Chalabianloo F, Økland JM, Leiva RAM, Vickerman P, Johansson KA, Fadnes LT (2020)
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
BMJ Open, 10 (8), e036355
DOI 10.1136/bmjopen-2019-036355, PubMed 32847908

Publications 2019

Ask H, Handal M, Hauge LJ, Reichborn-Kjennerud T, Skurtveit S (2019)
Incidence of diagnosed pediatric anxiety disorders and use of prescription drugs: a nation-wide registry study
Eur Child Adolesc Psychiatry, 29 (8), 1063-1073
DOI 10.1007/s00787-019-01419-0, PubMed 31641902

Evandt J, Skurtveit S, Oftedal B, Krog NH, Nafstad P, Skovlund E, Schwarze PE, Aasvang GM (2019)
Agreement between self-reported and registry-based use of sleep medications and tranquilizers
Pharmacoepidemiol Drug Saf, 28 (10), 1336-1343
DOI 10.1002/pds.4854, PubMed 31407838

Fadnes LT, Aas CF, Vold JH, Ohldieck C, Leiva RA, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA, INTRO-HCV Study Group (2019)
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
BMC Infect Dis, 19 (1), 943
DOI 10.1186/s12879-019-4598-7, PubMed 31703669

Fredheim OM, Skurtveit S, Handal M, Hjellvik V (2019)
A complete national cohort study of prescriptions of analgesics and benzodiazepines to cancer survivors in Norway 10 years after diagnosis
Pain, 160 (4), 852-859
DOI 10.1097/j.pain.0000000000001459, PubMed 30531310

Handal M, Nechanská B, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Mravčík V (2019)
Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway
Pharmacol Res Perspect, 7 (5), e00501
DOI 10.1002/prp2.501, PubMed 31428431

Hoff M, Skovlund E, Skurtveit S, Meyer HE, Langhammer A, Søgaard AJ, Syversen U, Forsmo S, Abrahamsen B, Schei B (2019)
Proton pump inhibitors and fracture risk. The HUNT study, Norway
Osteoporos Int, 31 (1), 109-118
DOI 10.1007/s00198-019-05206-0, PubMed 31741023

Lund IO, Skurtveit S, Handal M, Bukten A, Ask Torvik F, Ystrøm E, Burdzovic Andreas J (2019)
Association of Constellations of Parental Risk With Children's Subsequent Anxiety and Depression: Findings From a HUNT Survey and Health Registry Study
JAMA Pediatr, 173 (3), 251-259
DOI 10.1001/jamapediatrics.2018.4360, PubMed 30615089

Lupattelli A, Chambers CD, Bandoli G, Handal M, Skurtveit S, Nordeng H (2019)
Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers
JAMA Netw Open, 2 (4), e191435
DOI 10.1001/jamanetworkopen.2019.1435, PubMed 30951155

Muller AE, Clausen T, Sjøgren P, Odsbu I, Skurtveit S (2019)
Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017
Scand J Pain, 19 (2), 345-353
DOI 10.1515/sjpain-2018-0307, PubMed 30677000

Muller AE, Skurtveit S, Clausen T (2019)
Performance of the WHOQOL-BREF among Norwegian substance use disorder patients
BMC Med Res Methodol, 19 (1), 44
DOI 10.1186/s12874-019-0690-3, PubMed 30832564

Muller AE, Skurtveit S, Clausen T (2019)
Confirming the factor structure of a generic quality of life instrument among pre-treatment substance use disorder patients
Health Qual Life Outcomes, 17 (1), 84
DOI 10.1186/s12955-019-1152-7, PubMed 31101049

Munch EL, Skurtveit S, Handal M, Skovlund E (2019)
Pre conception use of cannabis and cocaine among men with pregnant partners
Nordisk Alkohol Nark, 37 (1), 43-53
DOI 10.1177/1455072519879564, PubMed 32934592

Skurtveit S, Nechanská B, Handal M, Mahic M, Mravčík V, Gabrhelík R (2019)
Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic
Addiction, 114 (7), 1225-1235
DOI 10.1111/add.14576, PubMed 30725515

Suren P, Bakken IJ, Skurtveit S, Handal M, Reichborn-Kjennerud T, Stoltenberg C, Nostvik LI, Weidle B (2019)
Tourette's syndrome in children in Norway
Tidsskr. Nor. Laegeforen., 139 (17), 1649-1653

Surén P, Bakken IJ, Skurtveit S, Handal M, Reichborn-Kjennerud T, Stoltenberg C, Nøstvik LI, Weidle B (2019)
Tourette syndrome in children in Norway
Tidsskr Nor Laegeforen, 139 (17)
DOI 10.4045/tidsskr.19.0411, PubMed 31746178

Surén P, Bakken IJ, Skurtveit S, Handal M, Reichborn-Kjennerud T, Stoltenberg C, Nøstvik LI, Weidle B (2019)
[Tourette syndrome in children in Norway]
Tidsskr Nor Laegeforen, 139 (18)
DOI 10.4045/tidsskr.19.0738, PubMed 31823585

Tveito M, Handal M, Engedal K, Smith RL, Hoiseth G, Skurtveit S (2019)
Prescribing antipsychotics to the elderly living at home 2006-2018
Tidsskr. Nor. Laegeforen., 139 (16), 1554-1558

Tveito M, Handal M, Engedal K, Smith RL, Høiseth G, Skurtveit S (2019)
[Prescribing of antipsychotic drugs to older patients living at home 2006–18]
Tidsskr Nor Laegeforen, 139 (16)
DOI 10.4045/tidsskr.19.0233, PubMed 31686488

Publications 2018

Birke H, Ekholm O, Sjøgren P, Fredheim O, Clausen T, Skurtveit S (2018)
Tramadol use in Norway: A register-based population study
Pharmacoepidemiol Drug Saf, 28 (1), 54-61
DOI 10.1002/pds.4626, PubMed 30073735

Egeland GM, Skurtveit S, Staff AC, Eide GE, Daltveit AK, Klungsøyr K, Trogstad L, Magnus PM, Brantsæter AL, Haugen M (2018)
Pregnancy-Related Risk Factors Are Associated With a Significant Burden of Treated Hypertension Within 10 Years of Delivery: Findings From a Population-Based Norwegian Cohort
J Am Heart Assoc, 7 (10)
DOI 10.1161/JAHA.117.008318, PubMed 29755036

Engeland A, Bjørge T, Klungsøyr K, Hjellvik V, Skurtveit S, Furu K (2018)
Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015
Pharmacoepidemiol Drug Saf, 27 (9), 995-1004
DOI 10.1002/pds.4577, PubMed 29920833

Heldal AT, Skurtveit S, Lobmaier PPK, Vederhus JK, Bramness JG (2018)
[Use of drugs for alcohol use disorder in Norway 2004–16]
Tidsskr Nor Laegeforen, 138 (18)
DOI 10.4045/tidsskr.18.0383, PubMed 30421743

Heldal AT, Skurtveit S, Lobmaier PPK, Vederhus JK, Bramness JG (2018)
Use of drugs for alcoholic disorders in Norway 2004-16
Tidsskr. Nor. Laegeforen., 138 (18), 1710-1715

Hoff M, Skurtveit S, Meyer HE, Langhammer A, Søgaard AJ, Syversen U, Skovlund E, Abrahamsen B, Forsmo S, Schei B (2018)
Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway
Osteoporos Int, 29 (8), 1875-1885
DOI 10.1007/s00198-018-4560-3, PubMed 29774403

Mauseth SA, Skurtveit S, Skovlund E, Langhammer A, Spigset O (2018)
Medication use and association with urinary incontinence in women: Data from the Norwegian Prescription Database and the HUNT study
Neurourol Urodyn, 37 (4), 1448-1457
DOI 10.1002/nau.23473, PubMed 29336066

Nechanská B, Mravčík V, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Handal M (2018)
Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway
Addiction, 113 (7), 1286-1294
DOI 10.1111/add.14192, PubMed 29443414

Nesvåg R, Bramness JG, Handal M, Hartz I, Hjellvik V, Skurtveit S (2018)
The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents
Eur Psychiatry, 49, 16-22
DOI 10.1016/j.eurpsy.2017.12.009, PubMed 29366845

Reset A, Skurtveit S, Furu K, Skovlund E (2018)
Effect of the market withdrawal of dextropropoxyphene on use of other prescribed analgesics
Scand J Pain, 18 (4), 667-674
DOI 10.1515/sjpain-2018-0103, PubMed 30145581

Skjaervo I, Clausen T, Skurtveit S, Abel KF, Bukten A (2018)
Similarities and Differences in Victimization Risk Factors for Nonoffending and Offending Substance Users
Victims Offenders, 13 (4), 526-541
DOI 10.1080/15564886.2017.1383332

Skurtveit S, Bramness JG, Hjellvik V, Hartz I, Nesvåg R, Hauge LJ, Handal M (2018)
Increase in diagnosis of depressive disorders contributes to the increase in antidepressant use in adolescents
Acta Psychiatr Scand, 137 (5), 413-421
DOI 10.1111/acps.12877, PubMed 29623693

Tverdal A, Skurtveit S, Selmer R, Myhre R, Thelle D (2018)
Coffee and wine consumption is associated with reduced mortality from alcoholic liver disease: follow-up of 219,279 Norwegian men and women aged 30-67 years
Ann Epidemiol, 28 (11), 753-758
DOI 10.1016/j.annepidem.2018.08.010, PubMed 30241792

Publications 2017

Bachmann CJ, Aagaard L, Bernardo M, Brandt L, Cartabia M, Clavenna A, Coma Fusté A, Furu K, Garuoliené K, Hoffmann F, Hollingworth S, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, López SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Piovani D, Reutfors J, Saastamoinen LK, Sato I et al. (2017)
International trends in clozapine use: a study in 17 countries
Acta Psychiatr Scand, 136 (1), 37-51
DOI 10.1111/acps.12742, PubMed 28502099

Brandlistuen RE, Ystrom E, Hernandez-Diaz S, Skurtveit S, Selmer R, Handal M, Nordeng H (2017)
Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study
PLoS One, 12 (7), e0181042
DOI 10.1371/journal.pone.0181042, PubMed 28746341

Bukten A, Stavseth MR, Skurtveit S, Tverdal A, Strang J, Clausen T (2017)
High risk of overdose death following release from prison: variations in mortality during a 15-year observation period
Addiction, 112 (8), 1432-1439
DOI 10.1111/add.13803, PubMed 28319291

Egeland GM, Skurtveit S, Sakshaug S, Daltveit AK, Vikse BE, Haugen M (2017)
Low Calcium Intake in Midpregnancy Is Associated with Hypertension Development within 10 Years after Pregnancy: The Norwegian Mother and Child Cohort Study
J Nutr, 147 (9), 1757-1763
DOI 10.3945/jn.117.251520, PubMed 28701386

Engeland A, Bjørge T, Klungsøyr K, Skurtveit S, Furu K (2017)
Preterm births and use of medication in early adulthood: a population-based registry study
Pharmacoepidemiol Drug Saf, 26 (7), 742-751
DOI 10.1002/pds.4174, PubMed 28168780

Evandt J, Oftedal B, Krog NH, Skurtveit S, Nafstad P, Schwarze PE, Skovlund E, Houthuijs D, Aasvang GM (2017)
Road traffic noise and registry based use of sleep medication
Environ Health, 16 (1), 110
DOI 10.1186/s12940-017-0330-5, PubMed 29078795

Fredheim OMS, Skurtveit S, Borchgrevink PC (2017)
[Provision of analgesics to children before and after the new recommendations on codeine]
Tidsskr Nor Laegeforen, 137 (12-13), 881-884
DOI 10.4045/tidsskr.16.0717, PubMed 28655238

Fredheim OMS, Skurtveit S, Borchgrevink PC (2017)
Delivery of analgesics to children before and after new recommendations on codeine
Tidsskr. Nor. Laegeforen., 137 (12-13), 881-884

Gjersing L, Jonassen K, Skurtveit S, Bramness J, Clausen T (2017)
Emergency service use is common in the year before death among drug users who die from an overdose
J. Subst. Use, 22 (3), 331-336
DOI 10.1080/14659891.2016.1208778

Hálfdánarson Ó, Zoëga H, Aagaard L, Bernardo M, Brandt L, Fusté AC, Furu K, Garuoliené K, Hoffmann F, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, Litchfield M, López SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Pearson SA, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM et al. (2017)
International trends in antipsychotic use: A study in 16 countries, 2005-2014
Eur Neuropsychopharmacol, 27 (10), 1064-1076
DOI 10.1016/j.euroneuro.2017.07.001, PubMed 28755801

Hoff M, Meyer HE, Skurtveit S, Langhammer A, Søgaard AJ, Syversen U, Dhainaut A, Skovlund E, Abrahamsen B, Schei B (2017)
Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway
Osteoporos Int, 28 (10), 2935-2944
DOI 10.1007/s00198-017-4134-9, PubMed 28668994

Holdø I, Bramness JG, Handal M, Torgersen L, Reichborn-Kjennerud T, Ystrøm E, Nordeng H, Skurtveit S (2017)
Hypnotics use in children 0-18 months: moderate agreement between mother-reported survey data and prescription registry data
J Pharm Policy Pract, 10, 28
DOI 10.1186/s40545-017-0117-7, PubMed 28904801

Johannsdottir IM, Loge JH, Kiserud CE, Karlstad Ø, Skurtveit S (2017)
Increased prescription rates of anxiolytics and hypnotics to survivors of cancer in childhood, adolescence, and young adulthood-A population-based study
Pediatr Blood Cancer, 65 (2)
DOI 10.1002/pbc.26860, PubMed 29077266

Lupattelli A, Wood M, Ystrom E, Skurtveit S, Handal M, Nordeng H (2017)
Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children
J Am Acad Child Adolesc Psychiatry, 57 (3), 200-208
DOI 10.1016/j.jaac.2017.12.010, PubMed 29496129

Mauseth SA, Skurtveit S, Langhammer A, Spigset O (2017)
Incidence of and factors associated with anticholinergic drug use among Norwegian women with urinary incontinence
Int Urogynecol J, 29 (4), 489-495
DOI 10.1007/s00192-017-3499-9, PubMed 29103164

Muller AE, Skurtveit S, Clausen T (2017)
Building abstinent networks is an important resource in improving quality of life
Drug Alcohol Depend, 180, 431-438
DOI 10.1016/j.drugalcdep.2017.09.006, PubMed 28988006

Skovlund E, Handal M, Selmer R, Brandlistuen RE, Skurtveit S (2017)
Language competence and communication skills in 3-year-old children after prenatal exposure to analgesic opioids
Pharmacoepidemiol Drug Saf, 26 (6), 625-634
DOI 10.1002/pds.4170, PubMed 28168770

Publications 2016

Brelin S, Fredheim OM, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ (2016)
Opioids for outpatients with cancer in their last year of life: A nationwide pharmacoepidemiological study
J Opioid Manag, 12 (1), 25-36
DOI 10.5055/jom.2016.0309, PubMed 26908301

Fredheim OM, Brelin S, Hjermstad MJ, Loge JH, Aass N, Johannesen TB, Skurtveit S (2016)
Prescriptions of analgesics during complete disease trajectories in patients who are diagnosed with and die from cancer within the five-year period 2005-2009
Eur J Pain, 21 (3), 530-540
DOI 10.1002/ejp.956, PubMed 27739657

Gabrhelík R, Nechanská B, Mravčík V, Skurtveit S, Lund IO, Handal M (2016)
A Unique Opportunity to Study Short and Long Term Consequences in Children Prenatally Exposed to Illicit Drugs and Opioid Maintenance Treatment Using Czech and Scandinavian Registers
Cent Eur J Public Health, 24 (3), 248-251
DOI 10.21101/cejph.a4474, PubMed 27743517

Handal M, Skurtveit S, Roth C, Hernandez-Diaz S, Selmer R (2016)
Prenatal Exposure to Folic Acid and Antidepressants and Language Development: A Population-Based Cohort Study
J Clin Psychopharmacol, 36 (4), 333-9
DOI 10.1097/JCP.0000000000000519, PubMed 27285658

Hartz I, Skurtveit S, Hjellvik V, Furu K, Nesvåg R, Handal M (2016)
Antidepressant drug use among adolescents during 2004-2013: a population-based register linkage study
Acta Psychiatr Scand, 134 (5), 420-429
DOI 10.1111/acps.12633, PubMed 27571234

Hartz I, Skurtveit S, Steffenak AK, Karlstad Ø, Handal M (2016)
Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study
BMC Psychiatry, 16, 12
DOI 10.1186/s12888-016-0716-x, PubMed 26822371

Johannsdottir IM, Karlstad Ø, Loge JH, Fosså SD, Kiserud C, Skurtveit S (2016)
Prescriptions of Antidepressants to Survivors of Cancer in Childhood, Adolescence, and Young Adulthood: A Population-Based Study
J Adolesc Young Adult Oncol, 6 (1), 120-126
DOI 10.1089/jayao.2016.0041, PubMed 27841952

Midgard H, Bramness JG, Skurtveit S, Haukeland JW, Dalgard O (2016)
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study
PLoS One, 11 (11), e0166451
DOI 10.1371/journal.pone.0166451, PubMed 27846264

Muller AE, Skurtveit S, Clausen T (2016)
Many correlates of poor quality of life among substance users entering treatment are not addiction-specific
Health Qual Life Outcomes, 14, 39
DOI 10.1186/s12955-016-0439-1, PubMed 26940259

Muller AE, Skurtveit S, Clausen T (2016)
Validating the generic quality of life tool "QOL10" in a substance use disorder treatment cohort exposes a unique social construct
BMC Med Res Methodol, 16, 60
DOI 10.1186/s12874-016-0163-x, PubMed 27216750

Nesvåg R, Hartz I, Bramness JG, Hjellvik V, Handal M, Skurtveit S (2016)
Mental disorder diagnoses among children and adolescents who use antipsychotic drugs
Eur Neuropsychopharmacol, 26 (9), 1412-1418
DOI 10.1016/j.euroneuro.2016.07.001, PubMed 27452144

Rognli EB, Bramness JG, Skurtveit S, Bukten A (2016)
Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample
J Subst Abuse Treat, 74, 42-47
DOI 10.1016/j.jsat.2016.12.007, PubMed 28132699

Sakshaug S, Handal M, Hjellvik V, Berg C, Ripel Å, Gustavsen I, Mørland J, Skurtveit S (2016)
Long-term Use of Z-Hypnotics and Co-medication with Benzodiazepines and Opioids
Basic Clin Pharmacol Toxicol, 120 (3), 292-298
DOI 10.1111/bcpt.12684, PubMed 27717229

Skjaervø I, Skurtveit S, Clausen T, Bukten A (2016)
Substance use pattern, self-control and social network are associated with crime in a substance-using population
Drug Alcohol Rev, 36 (2), 245-252
DOI 10.1111/dar.12406, PubMed 27147068

Tjagvad C, Clausen T, Handal M, Skurtveit S (2016)
Benzodiazepine prescription for patients in treatment for drug use disorders: a nationwide cohort study in Denmark, 2000-2010
BMC Psychiatry, 16, 168
DOI 10.1186/s12888-016-0881-y, PubMed 27234965

Tjagvad C, Skurtveit S, Bramness JG, Gjersing L, Gossop M, Clausen T (2016)
Misuse of prescription drugs and overdose deaths
J. Subst. Use, 21 (5), 515-520
DOI 10.3109/14659891.2015.1077280

Tjagvad C, Skurtveit S, Linnet K, Andersen LV, Christoffersen DJ, Clausen T (2016)
Methadone-Related Overdose Deaths in a Liberal Opioid Maintenance Treatment Programme
Eur Addict Res, 22 (5), 249-58
DOI 10.1159/000446429, PubMed 27246839

Publications 2015

Berg C, Skurtveit S, Sakshaug S, Hjellvik V, Handal M (2015)
Reduced prescribing of benzodiazepines in Denmark and Norway
Basic Clin Pharmacol Toxicol, 116 (6), 457-8
DOI 10.1111/bcpt.12377, PubMed 25612796

Bukten A, Lund IO, Rognli EB, Stavseth MR, Lobmaier P, Skurtveit S, Clausen T, Kunøe N (2015)
The Norwegian Offender Mental Health and Addiction Study - Design and Implementation of a National Survey and Prospective Cohort Study
Subst Abuse, 9 (Suppl 2), 59-66
DOI 10.4137/SaRt.S23546, PubMed 26648732

Dale O, Borchgrevink PC, Fredheim OM, Mahic M, Romundstad P, Skurtveit S (2015)
Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids
BMC Public Health, 15, 461
DOI 10.1186/s12889-015-1774-6, PubMed 25934132

Engeland A, Bjørge T, Klungsøyr K, Skjærven R, Skurtveit S, Furu K (2015)
Preeclampsia in pregnancy and later use of antihypertensive drugs
Eur J Epidemiol, 30 (6), 501-8
DOI 10.1007/s10654-015-0018-5, PubMed 25784365

Fredheim OM, Mahic M, Skurtveit S, Borchgrevink PC (2015)
Use of nasal fentanyl for cancer pain: A pharmacoepidemiological study
Palliat Med, 29 (7), 661-6
DOI 10.1177/0269216315575252, PubMed 25762579

Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R (2015)
Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study
BJOG, 123 (12), 1908-1917
DOI 10.1111/1471-0528.13582, PubMed 26374234

Hansen AB, Borchgrevink PC, Skurtveit S, Romundstad P, Fredheim OM (2015)
Consumption of and satisfaction with health care among opioid users with chronic non-malignant pain
Acta Anaesthesiol Scand, 60 (2), 276
DOI 10.1111/aas.12645, PubMed 26508281

Hansen AB, Skurtveit S, Borchgrevink PC, Dale O, Romundstad PR, Mahic M, Fredheim OM (2015)
Consumption of and satisfaction with health care among opioid users with chronic non-malignant pain
Acta Anaesthesiol Scand, 59 (10), 1355-66
DOI 10.1111/aas.12568, PubMed 26113028

Hartz I, Handal M, Tverdal A, Skurtveit S (2015)
Paediatric Off-Label Use of Melatonin--A Register Linkage Study between the Norwegian Prescription Database and Patient Register
Basic Clin Pharmacol Toxicol, 117 (4), 267-73
DOI 10.1111/bcpt.12411, PubMed 25892306

Hoff M, Skurtveit S, Meyer HE, Langhammer A, Søgaard AJ, Syversen U, Abrahamsen B, Schei B (2015)
Use of anti-osteoporotic drugs in central Norway after a forearm fracture
Arch Osteoporos, 10, 235
DOI 10.1007/s11657-015-0235-2, PubMed 26334427

Lund IO, Bukten A, Storvoll EE, Moan IS, Skurtveit S, Handal M, Nordfjaern T, Brunborg GS, Rossow I (2015)
A Cohort Study on Long-Term Adverse Effects of Parental Drinking: Background and Study Design
Subst Abuse, 9 (Suppl 2), 77-83
DOI 10.4137/SaRt.S23329, PubMed 26688663

Lund IO, Skurtveit S, Handal M (2015)
Commentary on Raitasalo et al. (2015): the great potential in nation-wide registers to study prescription drug use and abuse
Addiction, 110 (4), 644-5
DOI 10.1111/add.12856, PubMed 25771690

Mellbye A, Karlstad Ø, Skurtveit S, Borchgrevink PC, Fredheim OM (2015)
The duration and course of opioid therapy in patients with chronic non-malignant pain
Acta Anaesthesiol Scand, 60 (1), 128-37
DOI 10.1111/aas.12594, PubMed 26242816

Welle-Strand GK, Skurtveit S, Tanum L, Waal H, Bakstad B, Bjarkø L, Ravndal E (2015)
Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009
Eur Addict Res, 21 (5), 253-61
DOI 10.1159/000381670, PubMed 25967268

Publications 2014

Bukten A, Skurtveit S, Waal H, Clausen T (2014)
Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study
Addict Behav, 39 (10), 1504-9
DOI 10.1016/j.addbeh.2014.05.007, PubMed 24960556

Fredheim OMS, Mahic M, Skurtveit S, Dale O, Romundstad P, Borchgrevink PC (2014)
Chronic pain and use of opioids: a population-based pharmacoepidemiological study from the Norwegian prescription database and the Nord-Trøndelag health study
Pain, 155 (7), 1213-1221
DOI 10.1016/j.pain.2014.03.009, PubMed 24637039

Mahic M, Fredheim OM, Borchgrevink PC, Skurtveit S (2014)
Use of prescribed opioids by children and adolescents: Differences between Denmark, Norway and Sweden
Eur J Pain, 19 (8), 1095-100
DOI 10.1002/ejp.632, PubMed 25410553

Mellbye A, Karlstad Ø, Skurtveit S, Borchgrevink PC, Fredheim OM (2014)
Co-morbidity in persistent opioid users with chronic non-malignant pain in Norway
Eur J Pain, 18 (8), 1083-93
DOI 10.1002/j.1532-2149.2014.00449.x, PubMed 24443266

Odsbu I, Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M (2014)
Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age
Eur J Clin Pharmacol, 71 (3), 283-91
DOI 10.1007/s00228-014-1797-4, PubMed 25547568

Riska BS, Skurtveit S, Furu K, Engeland A, Handal M (2014)
Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study
Eur J Clin Pharmacol, 70 (11), 1367-74
DOI 10.1007/s00228-014-1744-4, PubMed 25204310

Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M (2014)
Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway
BJOG, 121 (13), 1621-31
DOI 10.1111/1471-0528.12821, PubMed 24726047

Svendsen K, Fredheim OM, Romundstad P, Borchgrevink PC, Skurtveit S (2014)
Persistent opioid use and socio-economic factors: a population-based study in Norway
Acta Anaesthesiol Scand, 58 (4), 437-45
DOI 10.1111/aas.12281, PubMed 24593770

Publications 2013

Bukten A, Herskedal A, Skurtveit S, Bramness JG, Clausen T (2013)
Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study
Addiction, 108 (11), 1954-61
DOI 10.1111/add.12275, PubMed 23773400

Bukten A, Røislien J, Skurtveit S, Waal H, Gossop M, Clausen T (2013)
A day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study
BMC Psychiatry, 13, 262
DOI 10.1186/1471-244X-13-262, PubMed 24131480

Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K (2013)
Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases
Br J Clin Pharmacol, 75 (4), 1134-41
DOI 10.1111/j.1365-2125.2012.04426.x, PubMed 22897396

Fredheim OMS, Borchgrevink PC, Mahic M, Skurtveit S (2013)
A pharmacoepidemiological cohort study of subjects starting strong opioids for nonmalignant pain: a study from the Norwegian Prescription Database
Pain, 154 (11), 2487-2493
DOI 10.1016/j.pain.2013.07.033, PubMed 24075311

Holdø I, Handal M, Skurtveit S, Bramness JG (2013)
Association between prescribing hypnotics for parents and children in Norway
Arch Dis Child, 98 (9), 732-6
DOI 10.1136/archdischild-2013-303646, PubMed 23845695

Karlstad Ø, Furu K, Skurtveit S, Selmer R (2013)
Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway
Eur Addict Res, 20 (2), 59-65
DOI 10.1159/000353969, PubMed 24080771

Lund IO, Skurtveit S, Sarfi M, Bakstad B, Welle-Strand G, Ravndal E (2013)
A 2-year prospective study of psychological distress among a national cohort of pregnant women in opioid maintenance treatment and their partners
J. Subst. Use, 18 (2), 148-160
DOI 10.3109/14659891.2011.642928

Mauseth SA, Skurtveit S, Spigset O (2013)
Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database
Acta Obstet Gynecol Scand, 92 (10), 1208-15
DOI 10.1111/aogs.12196, PubMed 23763552

Neutel CI, Skurtveit S, Berg C, Sakshaug S (2013)
Trends in prescription of strong opioids for 41-80 year old Norwegians, 2005-2010
Eur J Pain, 18 (3), 438-46
DOI 10.1002/j.1532-2149.2013.00374.x, PubMed 23900890

Neutel CI, Skurtveit S, Berg C, Sakshaug S (2013)
Multiple prescribers in older frequent opioid users--does it mean abuse?
J Popul Ther Clin Pharmacol, 20 (3), e397-405
PubMed 24201229

Neutel CI, Skurtveit S, Berg C, Sakshaug S (2013)
MULTIPLE PRESCRIBERS IN OLDER FREQUENT OPIOID USERS - DOES IT MEAN ABUSE?
J. Popul. Ther. Clin. Pharmacol., 20 (3), E397-E405

Skurtveit S, Selmer R, Tverdal A, Furu K, Nystad W, Handal M (2013)
Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations
J Clin Epidemiol, 66 (9), 964-72
DOI 10.1016/j.jclinepi.2013.02.011, PubMed 23800534

Welle-Strand GK, Skurtveit S, Jansson LM, Bakstad B, Bjarkø L, Ravndal E (2013)
Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants
Acta Paediatr, 102 (11), 1060-6
DOI 10.1111/apa.12378, PubMed 23909865

Publications 2012

Bramness JG, Furu K, Skurtveit S, Engeland A (2012)
Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential
Clin Pharmacol Ther, 91 (3), 438-41
DOI 10.1038/clpt.2011.250, PubMed 22318620

Bramness JG, Skurtveit S, Mørland J, Engeland A (2012)
An increased risk of motor vehicle accidents after prescription of methadone
Addiction, 107 (5), 967-72
DOI 10.1111/j.1360-0443.2011.03745.x, PubMed 22151376

Brelin S, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ (2012)
Antidepressants to cancer patients during the last year of life--a population-based study
Psychooncology, 22 (3), 506-14
DOI 10.1002/pon.3059, PubMed 22392773

Devold HM, Furu K, Skurtveit S, Tverdal A, Falch JA, Sogaard AJ (2012)
Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway
Pharmacoepidemiol Drug Saf, 21 (3), 297-304
DOI 10.1002/pds.2344, PubMed 22237942

Handal M, Skurtveit S, Mørland JG (2012)
[Co-medication with benzodiazepines]
Tidsskr Nor Laegeforen, 132 (5), 526-30
DOI 10.4045/tidsskr.11.0321, PubMed 22398769

Hartz I, Furu K, Bratlid T, Handal M, Skurtveit S (2012)
Hypnotic drug use among 0-17 year olds during 2004-2011: a nationwide prescription database study
Scand J Public Health, 40 (8), 704-11
DOI 10.1177/1403494812464446, PubMed 23108475

Log T, Skurtveit S, Selmer R, Tverdal A, Furu K, Hartz I (2012)
The association between prescribed opioid use for mothers and children: a record-linkage study
Eur J Clin Pharmacol, 69 (1), 111-8
DOI 10.1007/s00228-012-1312-8, PubMed 22684128

Lund IO, Skurtveit S, Engeland A, Furu K, Ravndal E, Handal M (2012)
Prescription drug use among pregnant women in opioid Maintenance Treatment
Addiction, 108 (2), 367-76
DOI 10.1111/j.1360-0443.2012.04049.x, PubMed 22882166

Lund IO, Skurtveit S, Sarfi M, Bakstad B, Welle-Strand G, Ravndal E (2012)
Substance use during and after pregnancy among a national cohort of pregnant women in opioid maintenance treatment and their partners
J. Subst. Use, 17 (3), 277-286
DOI 10.3109/14659891.2011.580415

Mellbye A, Svendsen K, Borchgrevink PC, Skurtveit S, Fredheim OM (2012)
Concomitant medication among persistent opioid users with chronic non-malignant pain
Acta Anaesthesiol Scand, 56 (10), 1267-76
DOI 10.1111/j.1399-6576.2012.02766.x, PubMed 22946822

Neutel CI, Skurtveit S, Berg C (2012)
What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population
Sleep Med, 13 (7), 893-7
DOI 10.1016/j.sleep.2011.12.014, PubMed 22704401

Pedersen L, Hansen AB, Svendsen K, Skurtveit S, Borchgrevink PC, Fredheim OM (2012)
Reimbursement of analgesics for chronic pain
Tidsskr Nor Laegeforen, 132 (22), 2489-93
DOI 10.4045/tidsskr.11.1214, PubMed 23338029

Skollerud LM, Fredheim OM, Svendsen K, Skurtveit S, Borchgrevink PC (2012)
Laxative prescriptions to cancer outpatients receiving opioids: a study from the Norwegian prescription database
Support Care Cancer, 21 (1), 67-73
DOI 10.1007/s00520-012-1494-8, PubMed 22653367

Steffenak AK, Nordström G, Wilde-Larsson B, Skurtveit S, Furu K, Hartz I (2012)
Mental distress and subsequent use of psychotropic drugs among adolescents-a prospective register linkage study
J Adolesc Health, 50 (6), 578-87
DOI 10.1016/j.jadohealth.2011.10.011, PubMed 22626484

Steffenak AK, Wilde-Larsson B, Nordström G, Skurtveit S, Hartz I (2012)
Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study
Clin Epidemiol, 4, 225-31
DOI 10.2147/CLEP.S31624, PubMed 22936858

Welle-Strand GK, Skurtveit S, Jones HE, Waal H, Bakstad B, Bjarkø L, Ravndal E (2012)
Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009
Drug Alcohol Depend, 127 (1-3), 200-6
DOI 10.1016/j.drugalcdep.2012.07.001, PubMed 22841456

Publications 2011

Bukten A, Skurtveit S, Gossop M, Waal H, Stangeland P, Havnes I, Clausen T (2011)
Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study
Addiction, 107 (2), 393-9
DOI 10.1111/j.1360-0443.2011.03637.x, PubMed 21883606

Bukten A, Skurtveit S, Stangeland P, Gossop M, Willersrud AB, Waal H, Havnes I, Clausen T (2011)
Criminal convictions among dependent heroin users during a 3-year period prior to opioid maintenance treatment: a longitudinal national cohort study
J Subst Abuse Treat, 41 (4), 407-14
DOI 10.1016/j.jsat.2011.06.006, PubMed 21839605

Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K (2011)
Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway
Eur J Epidemiol, 26 (2), 157-63
DOI 10.1007/s10654-010-9527-4, PubMed 21298469

Fredheim OM, Borchgrevink PC, Nordstrand B, Clausen T, Skurtveit S (2011)
Prescription of analgesics to patients in opioid maintenance therapy: a pharmacoepidemiological study
Drug Alcohol Depend, 116 (1-3), 158-62
DOI 10.1016/j.drugalcdep.2010.12.014, PubMed 21277710

Fredheim OM, Moksnes K, Borchgrevink PC, Skurtveit S (2011)
Opioid switching to methadone: a pharmacoepidemiological study from a national prescription database
Palliat Med, 26 (6), 804-12
DOI 10.1177/0269216311412415, PubMed 21697266

Furu K, Karlstad Ø, Skurtveit S, Håberg SE, Nafstad P, London SJ, Nystad W (2011)
High validity of mother-reported use of antiasthmatics among children: a comparison with a population-based prescription database
J Clin Epidemiol, 64 (8), 878-84
DOI 10.1016/j.jclinepi.2010.10.014, PubMed 21232920

Handal M, Engeland A, Rønning M, Skurtveit S, Furu K (2011)
Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study
Eur J Clin Pharmacol, 67 (9), 953-60
DOI 10.1007/s00228-011-1030-7, PubMed 21484468

Ineke Neutel C, Skurtveit S, Berg C (2011)
Polypharmacy of potentially addictive medication in the older persons--quantifying usage
Pharmacoepidemiol Drug Saf, 21 (2), 199-206
DOI 10.1002/pds.2214, PubMed 21796722

Karlstad O, Tverdal A, Skurtveit S, Nafstad P, Furu K (2011)
A prospective study of asthma and subsequent use of hypnotics in young adults
Pharmacoepidemiol Drug Saf, 20 (4), 370-7
DOI 10.1002/pds.2101, PubMed 21264987

Karlstad Ø, Nafstad P, Tverdal A, Skurtveit S, Furu K (2011)
Comorbidities in an asthma population 8-29 years old: a study from the Norwegian Prescription Database
Pharmacoepidemiol Drug Saf, 21 (10), 1045-52
DOI 10.1002/pds.2233, PubMed 21953881

Log T, Skurtveit S, Tverdal A, Furu K, Hartz I (2011)
Dispensing of prescribed analgesics in Norway among young people with foreign-or Norwegian-born parents
Scand J Pain, 2 (1), 36-44
DOI 10.1016/j.sjpain.2010.11.001, PubMed 29914000

Nordbø A, Skurtveit S, Borchgrevink PC, Kaasa S, Fredheim OM (2011)
Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugs
Acta Anaesthesiol Scand, 56 (1), 88-94
DOI 10.1111/j.1399-6576.2011.02537.x, PubMed 22092357

Skurtveit S, Furu K, Borchgrevink P, Handal M, Fredheim O (2011)
To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use?
Pain, 152 (7), 1555-1561
DOI 10.1016/j.pain.2011.02.045, PubMed 21450405

Svendsen K, Skurtveit S, Romundstad P, Borchgrevink PC, Fredheim OM (2011)
Differential patterns of opioid use: defining persistent opioid use in a prescription database
Eur J Pain, 16 (3), 359-69
DOI 10.1002/j.1532-2149.2011.00018.x, PubMed 22337119

Publications 2010

Bramness JG, Sandvik P, Engeland A, Skurtveit S (2010)
Does Pregabalin (Lyrica(®) ) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database
Basic Clin Pharmacol Toxicol, 107 (5), 883-6
DOI 10.1111/j.1742-7843.2010.00590.x, PubMed 22545971

Fredheim OM, Log T, Olsen W, Skurtveit S, Sagen Ø, Borchgrevink PC (2010)
Prescriptions of opioids to children and adolescents; a study from a national prescription database in Norway
Paediatr Anaesth, 20 (6), 537-44
DOI 10.1111/j.1460-9592.2010.03310.x, PubMed 20609118

Hartz I, Tverdal A, Skille E, Skurtveit S (2010)
Disability pension as predictor of later use of benzodiazepines among benzodiazepine users
Soc Sci Med, 70 (6), 921-5
DOI 10.1016/j.socscimed.2009.11.015, PubMed 20071064

Hausken AM, Furu K, Tverdal A, Skurtveit S (2010)
Mental distress and subsequent use of anxiolytic drugs--a prospective population-based cohort study of 16,000 individuals
Scand J Public Health, 38 (5), 465-73
DOI 10.1177/1403494810370229, PubMed 20522514

Log T, Hartz I, Handal M, Tverdal A, Furu K, Skurtveit S (2010)
The association between smoking and subsequent repeated use of prescribed opioids among adolescents and young adults--a population-based cohort study
Pharmacoepidemiol Drug Saf, 20 (1), 90-8
DOI 10.1002/pds.2066, PubMed 21182157

Mahic M, Skurtveit S, Selmer R, Rønning M, Furu K (2010)
Prevalence, incidence and persistence of etanercept and adalimumab in Norway 2005-2009
Pharmacoepidemiol Drug Saf, 20 (5), 457-63
DOI 10.1002/pds.2091, PubMed 21523848

Skurtveit S, Furu K, Bramness J, Selmer R, Tverdal A (2010)
Benzodiazepines predict use of opioids--a follow-up study of 17,074 men and women
Pain Med, 11 (6), 805-14
DOI 10.1111/j.1526-4637.2010.00870.x, PubMed 20624237

Skurtveit S, Furu K, Selmer R, Handal M, Tverdal A (2010)
Nicotine dependence predicts repeated use of prescribed opioids. Prospective population-based cohort study
Ann Epidemiol, 20 (12), 890-7
DOI 10.1016/j.annepidem.2010.03.010, PubMed 20627770

Publications 2009

Bachs LC, Engeland A, Mørland JG, Skurtveit S (2009)
The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol
Clin Pharmacol Ther, 85 (6), 596-9
DOI 10.1038/clpt.2009.14, PubMed 19279562

Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A (2009)
An increased risk of road traffic accidents after prescriptions of lithium or valproate?
Pharmacoepidemiol Drug Saf, 18 (6), 492-6
DOI 10.1002/pds.1740, PubMed 19326366

Devold HM, Molden E, Skurtveit S, Furu K (2009)
Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy
Br J Clin Pharmacol, 67 (2), 234-41
DOI 10.1111/j.1365-2125.2008.03345.x, PubMed 19220274

Fredheim OM, Skurtveit S, Breivik H, Borchgrevink PC (2009)
Increasing use of opioids from 2004 to 2007 - pharmacoepidemiological data from a complete national prescription database in Norway
Eur J Pain, 14 (3), 289-94
DOI 10.1016/j.ejpain.2009.05.006, PubMed 19505834

Fredheim OM, Skurtveit S, Moroz A, Breivik H, Borchgrevink PC (2009)
Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database
Acta Anaesthesiol Scand, 53 (5), 627-33
DOI 10.1111/j.1399-6576.2009.01910.x, PubMed 19419357

Hartz I, Lundesgaard E, Tverdal A, Skurtveit S (2009)
Disability pension is associated with the use of benzodiazepines 20 years later: a prospective study
Scand J Public Health, 37 (3), 320-6
DOI 10.1177/1403494808101372, PubMed 19181823

Håkonsen GD, Pettersen MH, Skurtveit S, Giverhaug T (2009)
[Concomitant use of warfarin, analgesics and anti-inflammatory agents]
Tidsskr Nor Laegeforen, 129 (12), 1217-20
DOI 10.4045/tidsskr.08.0127, PubMed 19521444

Karlstad O, Nafstad P, Tverdal A, Skurtveit S, Furu K (2009)
Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study
Eur J Clin Pharmacol, 66 (4), 399-406
DOI 10.1007/s00228-009-0749-x, PubMed 19936728

Skurtveit S, Strøm H, Skrivarhaug T, Mørland J, Bramness JG, Engeland A (2009)
Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study
Diabet Med, 26 (4), 404-8
DOI 10.1111/j.1464-5491.2009.02699.x, PubMed 19388971

Publications 2008

Bramness JG, Skurtveit S (2008)
Carisoprodol should be taken off the market
South Med J, 101 (10), 1074-5
DOI 10.1097/SMJ.0b013e318184ac60, PubMed 18791514

Bramness JG, Skurtveit S, Gustavsen I, Mørland J (2008)
The absence of evidence is not the same as evidence for absence!
Addiction, 103 (3), 513-4
DOI 10.1111/j.1360-0443.2007.02103.x, PubMed 18269374

Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A (2008)
Minor increase in risk of road traffic accidents after prescriptions of antidepressants: a study of population registry data in Norway
J Clin Psychiatry, 69 (7), 1099-103
DOI 10.4088/jcp.v69n0709, PubMed 18588362

Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K (2008)
Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006
Br J Clin Pharmacol, 65 (5), 653-60
DOI 10.1111/j.1365-2125.2008.03102.x, PubMed 18294334

Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Mørland J (2008)
Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam
Sleep Med, 9 (8), 818-22
DOI 10.1016/j.sleep.2007.11.011, PubMed 18226959

Handal M, Ripel A, Skurtveit S, Mørland J (2008)
Behavioural sensitization in mice induced by morphine-glucuronide metabolites
Pharmacol Biochem Behav, 90 (4), 578-85
DOI 10.1016/j.pbb.2008.04.018, PubMed 18555521

Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness JG (2008)
Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors
Eur J Clin Pharmacol, 65 (3), 295-301
DOI 10.1007/s00228-008-0565-8, PubMed 18810397

Selmer R, Sakshaug S, Skurtveit S, Furu K, Tverdal A (2008)
Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education
Br J Clin Pharmacol, 67 (3), 355-62
DOI 10.1111/j.1365-2125.2008.03360.x, PubMed 19523016

Skurtveit S, Furu K, Bramness JG, Tverdal A (2008)
Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later--a follow-up study of 13,390 men and women aged 40-42 years
Pharmacoepidemiol Drug Saf, 17 (9), 926-933
DOI 10.1002/pds.1616, PubMed 18489010

Skurtveit S, Furu K, Kaasa S, Borchgrevink PC (2008)
Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
Eur J Pain, 13 (9), 949-53
DOI 10.1016/j.ejpain.2008.11.005, PubMed 19095476

Skurtveit S, Selmer R, Tverdal A, Furu K (2008)
The validity of self-reported prescription medication use among adolescents varied by therapeutic class
J Clin Epidemiol, 61 (7), 714-7
DOI 10.1016/j.jclinepi.2007.11.013, PubMed 18538265

Publications 2007

Bramness JG, Furu K, Engeland A, Skurtveit S (2007)
Carisoprodol use and abuse in Norway: a pharmacoepidemiological study
Br J Clin Pharmacol, 64 (2), 210-8
DOI 10.1111/j.1365-2125.2007.02847.x, PubMed 17298482

Bramness JG, Skurtveit S, Mørland J, Engeland A (2007)
The risk of traffic accidents after prescriptions of carisoprodol
Accid Anal Prev, 39 (5), 1050-5
DOI 10.1016/j.aap.2007.02.002, PubMed 17854578

Engeland A, Skurtveit S, Mørland J (2007)
Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study
Ann Epidemiol, 17 (8), 597-602
DOI 10.1016/j.annepidem.2007.03.009, PubMed 17574863

Furu K, Skurtveit S, Langhammer A, Nafstad P (2007)
Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis
Eur J Clin Pharmacol, 63 (7), 693-8
DOI 10.1007/s00228-007-0301-9, PubMed 17473919

Graff-Iversen S, Selmer R, Sørensen M, Skurtveit S (2007)
Occupational physical activity, overweight, and mortality: a follow-up study of 47,405 Norwegian women and men
Res Q Exerc Sport, 78 (3), 151-61
DOI 10.1080/02701367.2007.10599412, PubMed 17679488

Grung M, Källqvist T, Sakshaug S, Skurtveit S, Thomas KV (2007)
Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline
Ecotoxicol Environ Saf, 71 (2), 328-40
DOI 10.1016/j.ecoenv.2007.10.015, PubMed 18068226

Handal M, Ripel A, Aasmundstad T, Skurtveit S, Mørland J (2007)
Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice
Pharmacol Biochem Behav, 86 (3), 576-86
DOI 10.1016/j.pbb.2007.02.001, PubMed 17343905

Hartz I, Sakshaug S, Furu K, Engeland A, Eggen AE, Njølstad I, Skurtveit S (2007)
Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study
BMC Clin Pharmacol, 7, 14
DOI 10.1186/1472-6904-7-14, PubMed 18053228

Hausken AM, Skurtveit S, Rosvold EO, Bramness JG, Furu K (2007)
Psychotropic drug use among persons with mental distress symptoms: a population-based study in Norway
Scand J Public Health, 35 (4), 356-64
DOI 10.1080/14034940601159161, PubMed 17786798

Hausken AM, Skurtveit S, Tverdal A (2007)
Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population
Pharmacoepidemiol Drug Saf, 16 (8), 913-8
DOI 10.1002/pds.1417, PubMed 17486666

Heiberg E, Skurtveit S, Helsing E, Chalmers B (2007)
Women's experiences of giving birth in Northwest Russia in 2000 and 2002 and in Northern Norway 2000
Acta Obstet Gynecol Scand, 86 (3), 373-5
DOI 10.1080/00016340601124144, PubMed 17364316

Sakshaug S, Furu K, Karlstad Ø, Rønning M, Skurtveit S (2007)
Switching statins in Norway after new reimbursement policy: a nationwide prescription study
Br J Clin Pharmacol, 64 (4), 476-81
DOI 10.1111/j.1365-2125.2007.02907.x, PubMed 17441934

Publications 2006

Bachs L, Høiseth G, Skurtveit S, Mørland J (2006)
Heroin-using drivers: importance of morphine and morphine-6-glucuronide on late clinical impairment
Eur J Clin Pharmacol, 62 (11), 905-12
DOI 10.1007/s00228-006-0195-y, PubMed 17021891

Bramness JG, Skurtveit S, Furu K, Engeland A, Sakshaug S, Rønning M (2006)
[Changes in the sale and use of flunitrazepam in Norway after 1999]
Tidsskr Nor Laegeforen, 126 (5), 589-90
PubMed 16505866

Hartz I, Njølstad I, Furu K, Skurtveit S, Elise Eggen A (2006)
Why do sales of lipid-lowering drugs vary between counties in Norway? Evidence from the OPPHED Health Study 2000-2001
Scand J Prim Health Care, 24 (2), 115-21
DOI 10.1080/02813430500475365, PubMed 16690561

Publications 2005

Amundsen EJ, Rossow I, Skurtveit S (2005)
Drinking pattern among adolescents with immigrant and Norwegian backgrounds: a two-way influence?
Addiction, 100 (10), 1453-63
DOI 10.1111/j.1360-0443.2005.01177.x, PubMed 16185207

Bramness JG, Hausken AM, Sakshaug S, Skurtveit S, Rønning M (2005)
[Prescription of selective serotonin reuptake inhibitors 1990-2004]
Tidsskr Nor Laegeforen, 125 (18), 2470-3
PubMed 16186862

Bramness JG, Skurtveit S, Gulliksen M, Breilid H, Steen VM, Mørland J (2005)
The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects
Eur J Clin Pharmacol, 61 (7), 499-506
DOI 10.1007/s00228-005-0970-1, PubMed 16021435

Bramness JG, Skurtveit S, Mørland J (2005)
Flunitrazepam: psychomotor impairment, agitation and paradoxical reactions
Forensic Sci Int, 159 (2-3), 83-91
DOI 10.1016/j.forsciint.2005.06.009, PubMed 16087304

Furu K, Skurtveit S, Rosvold EO (2005)
[Self-reported medical drug use among 15-16 year-old adolescents in Norway]
Tidsskr Nor Laegeforen, 125 (20), 2759-61
PubMed 16244674

Hausken AM, Skurtveit S, Christophersen AS (2005)
Mortality among subjects previously apprehended for driving under the influence of traffic-hazardous medicinal drugs
Drug Alcohol Depend, 79 (3), 423-9
DOI 10.1016/j.drugalcdep.2005.03.014, PubMed 16102382

Heiberg E, Skurtveit S (2005)
[Women's voices in the Northwest Russia]
Tidsskr Nor Laegeforen, 125 (20), 2826-8
PubMed 16244695

Kristoffersen L, Skuterud B, Larssen BR, Skurtveit S, Smith-Kielland A (2005)
Fast quantification of ethanol in whole blood specimens by the enzymatic alcohol dehydrogenase method. Optimization by experimental design
J Anal Toxicol, 29 (1), 66-70
DOI 10.1093/jat/29.1.66, PubMed 15808017

Skurtveit S, Rosvold EO, Furu K (2005)
Use of psychotropic drugs in an urban adolescent population: the impact of health-related variables, lifestyle and sociodemographic factors--The Oslo Health Study 2000-2001
Pharmacoepidemiol Drug Saf, 14 (4), 277-83
DOI 10.1002/pds.1078, PubMed 15704236

Publications 2004

Bramness JG, Skurtveit S, Mørland J (2004)
Impairment due to intake of carisoprodol
Drug Alcohol Depend, 74 (3), 311-8
DOI 10.1016/j.drugalcdep.2004.01.007, PubMed 15194209

Hausken AM, Skurtveit S, Christophersen AS (2004)
Characteristics of drivers testing positive for heroin or ecstasy in Norway
Traffic Inj Prev, 5 (2), 107-11
DOI 10.1080/15389580490434953, PubMed 15203944

Tonstad S, Furu K, Rosvold EO, Skurtveit S (2004)
Determinants of control of high blood pressure. The Oslo Health Study 2000-2001
Blood Press, 13 (6), 343-9
DOI 10.1080/08037050410003982, PubMed 15771218

Tonstad S, Rosvold EO, Furu K, Skurtveit S (2004)
Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001
J Intern Med, 255 (4), 494-502
DOI 10.1111/j.1365-2796.2004.01315.x, PubMed 15049884

Publications 2003

Bachs L, Skurtveit S, Mørland J (2003)
Codeine and clinical impairment in samples in which morphine is not detected
Eur J Clin Pharmacol, 58 (12), 785-9
DOI 10.1007/s00228-003-0561-y, PubMed 12698303

Bramness JG, Skurtveit S, Fauske L, Grung M, Molven A, Mørland J, Steen VM (2003)
Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?
Pharmacogenetics, 13 (7), 383-8
DOI 10.1097/01.fpc.0000054098.48725.88, PubMed 12835613

Bramness JG, Skurtveit S, Mørland J (2003)
Testing for benzodiazepine inebriation--relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers
Eur J Clin Pharmacol, 59 (8-9), 593-601
DOI 10.1007/s00228-003-0677-0, PubMed 14504853

Christophersen AS, Skurtveit S, Mørland J (2003)
[Impaired driving as an indicator of drug abuse: what consequences for treatment?]
Tidsskr Nor Laegeforen, 123 (13-14), 1841-3
PubMed 12830259

Skurtveit S, Tverdal A (2003)
Erratum to "Sex differences in gamma-glutamyltransferase in people aged 40-42 years in two Norwegian counties"
Drug Alcohol Depend, 69 (1), 103-6
DOI 10.1016/s0376-8716(02)00319-8, PubMed 12760341

Skurtveit S, Tverdal A (2003)
Sex differences in gamma-glutamyltransferase in people aged 40-42 years in two Norwegian counties (vol 67, pg 95, 2002)
Drug Alcohol Depend., 69 (1), PII S0376-8716(02)00318-6-+
DOI 10.1016/S0376-8716(02)00318-6

Tverdal A, Skurtveit S (2003)
Coffee intake and mortality from liver cirrhosis
Ann Epidemiol, 13 (6), 419-23
DOI 10.1016/s1047-2797(02)00462-3, PubMed 12875799

Publications 2002

Bramness JG, Skurtveit S, Mørland J (2002)
Clinical impairment of benzodiazepines--relation between benzodiazepine concentrations and impairment in apprehended drivers
Drug Alcohol Depend, 68 (2), 131-41
DOI 10.1016/s0376-8716(02)00188-6, PubMed 12234642

Christophersen AS, Skurtveit S, Grung M, Mørland J (2002)
Rearrest rates among Norwegian drugged drivers compared with drunken drivers
Drug Alcohol Depend, 66 (1), 85-92
DOI 10.1016/s0376-8716(01)00187-9, PubMed 11850140

Handal M, Grung M, Skurtveit S, Ripel A, Mørland J (2002)
Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity
Pharmacol Biochem Behav, 73 (4), 883-92
DOI 10.1016/s0091-3057(02)00925-5, PubMed 12213535

Skurtveit S, Abotnes B, Christophersen AS (2002)
Drugged drivers in Norway with benzodiazepine detections
Forensic Sci Int, 125 (1), 75-82
DOI 10.1016/s0379-0738(01)00623-5, PubMed 11852205

Skurtveit S, Christophersen AS, Grung M, Mørland J (2002)
Increased mortality among previously apprehended drunken and drugged drivers
Drug Alcohol Depend, 68 (2), 143-50
DOI 10.1016/s0376-8716(02)00185-0, PubMed 12234643

Skurtveit S, Tverdal A (2002)
Sex differences in gamma-glutamyltransferase in people aged 40-42 years in two Norwegian counties
Drug Alcohol Depend, 67 (1), 95-8
DOI 10.1016/s0376-8716(02)00015-7, PubMed 12062783

Publications 2001

Graff-Iversen S, Skurtveit S, Nybø A, Ross GB (2001)
[Trends when it comes to occupational physical activity among Norwegians aged 40-42 years during the period 1974-94]
Tidsskr Nor Laegeforen, 121 (22), 2584-8
PubMed 11668753

Graff-Iversen S, Skurtveit S, Sørensen M, Nybø A (2001)
[What are the associations between occupational physical activity and overweight?]
Tidsskr Nor Laegeforen, 121 (22), 2579-83
PubMed 11668752

Publications 2000

Bramness JG, Skurtveit S, Grung M, Mørland J (2000)
[Centrally acting muscle relaxants and traffic hazards]
Tidsskr Nor Laegeforen, 120 (17), 1966-9
PubMed 11008526

Grung M, Skurtveit S, Ripel A, Mørland J (2000)
Lack of crosstolerance between morphine and morphine-6-glucuronide as revealed by locomotor activity
Pharmacol Biochem Behav, 66 (1), 205-10
DOI 10.1016/s0091-3057(00)00208-2, PubMed 10837862

Publications 1999

Bramness JG, Skurtveit S, Mørland J (1999)
[Detection of zopiclone in many drivers--a sign of misuse or abuse]
Tidsskr Nor Laegeforen, 119 (19), 2820-1
PubMed 10494203

Skurtveit S, Christophersen AS, Beylich KM, Mørland J (1999)
[Repeated driving under influence]
Tidsskr Nor Laegeforen, 119 (7), 959-63
PubMed 10210957

Publications 1998

Grung M, Skurtveit S, Aasmundstad TA, Handal M, Alkana RL, Mørland J (1998)
Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors
Pharmacol Toxicol, 82 (1), 3-10
DOI 10.1111/j.1600-0773.1998.tb01390.x, PubMed 9527644

Skurtveit S, Christophersen AS, Beylich KM, Bjørneboe A, Mørland J (1998)
Study of rearrests for drunken driving in Norway
Forensic Sci Int, 92 (1), 21-8
DOI 10.1016/s0379-0738(97)00199-0, PubMed 9627972

Publications 1996

Christophersen AS, Beylich KM, Bjørnboe A, Skurtveit S, Mørland J (1996)
Recidivism among drunken and drugged drivers in Norway
Alcohol Alcohol, 31 (6), 609-11
DOI 10.1093/oxfordjournals.alcalc.a008198, PubMed 9010552

Publications 1995

Skurtveit S, Christophersen AS, Mørland J (1995)
[Driving under the influence of benzodiazepines. Sale differences in the counties are reflected among drivers suspected of driving under the influence of a drug]
Tidsskr Nor Laegeforen, 115 (2), 200-3
PubMed 7855809

Skurtveit S, Christophersen AS, Mørland J (1995)
Female drivers suspected for drunken or drugged driving
Forensic Sci Int, 75 (2-3), 139-48
DOI 10.1016/0379-0738(95)01785-2, PubMed 8586337